Gene · 7486
Papers3,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive review on Fanconi anemia: insights into DNA interstrand cross-links, repair pathways, and associated tumors. | Orphanet J Rare Dis | 2025 | 40739565 | PubTator, text mining | PubMed |
| Comprehensive identification of NRG1 fusions in 25,203 patients with solid tumors. | NPJ Precis Oncol | 2025 | 40730881 | PubTator, text mining | PubMed |
| An overview of RecQ helicases and related diseases. | Aging (Albany NY) | 2025 | 40728512 | PubTator, text mining | PubMed |
| Participants in Transcription-Replication Conflict and Their Role in Formation and Resolution of R-Loops. | Int J Mol Sci | 2025 | 40725198 | PubTator, text mining | PubMed |
| Using the safety scissors: DNA resection regulation at DNA double-strand breaks and telomeres. | DNA Repair (Amst) | 2025 | 40716322 | PubTator, text mining | PubMed |
| Targeting WRN helicase: Discovery and development of its selective inhibitors. | Bioorg Chem | 2025 | 40714480 | PubTator, text mining | PubMed |
| Werner syndrome due to homozygous WRN mutation through chromosome 8 region of homozygosity in a consanguineous family. | Geriatr Gerontol Int | 2025 | 40693444 | PubTator, text mining | PubMed |
| Quinazoline Derivative kzl052 Suppresses Prostate Cancer by Targeting WRN Helicase to Stabilize DNA Replication Forks. | Int J Mol Sci | 2025 | 40649870 | PubTator, text mining | PubMed |
| Thioguanine-coordinated assembly for synthetic lethality of colorectal cancer with defective mismatch repair. | Chem Commun (Camb) | 2025 | 40637085 | PubTator, text mining | PubMed |
| Synthetic Lethality as Emerging Treatment for Cancer: An Example by Using the Werner Syndrome Helicase (WRN) Inhibitors. | ACS Med Chem Lett | 2025 | 40529098 | PubTator, text mining | PubMed |
| Targeting Werner Syndrome Helicase with Small Molecules in Mismatch Repair-Deficient Cancers. | ACS Med Chem Lett | 2025 | 40529095 | PubTator, text mining | PubMed |
| WRN as a Novel Target of Synthetic Lethality: Current Advances and Future Perspectives. | J Med Chem | 2025 | 40526642 | PubTator, text mining | PubMed |
| Validation, Key Pharmacophores, and X-ray Cocrystal Structures of Novel Biochemically and Cellularly Active WRN Inhibitors Derived from a DNA-Encoded Library Screen. | J Med Chem | 2025 | 40472162 | PubTator, text mining | PubMed |
| Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double-Blind Randomized Crossover Placebo-Controlled Trial. | Aging Cell | 2025 | 40459998 | PubTator, text mining | PubMed |
| [Molecular genetics in pediatric endocrinology: 35 years of research]. | Probl Endokrinol (Mosk) | 2025 | 40411325 | PubTator, text mining | PubMed |
| During recombinase-mediated homology recognition RecQ helicases inhibit formation of toxic long-lived D-loops that could promote genomic instability. | Nucleic Acids Res | 2025 | 40377216 | PubTator, text mining | PubMed |
| Crosstalk with infant-derived Th17 cells, as well as exposure to IL-22 promotes maturation of intestinal epithelial cells in an enteroid model. | Front Immunol | 2025 | 40375988 | PubTator, text mining | PubMed |
| Next-Generation Sequencing in Oncology-A Guiding Compass for Targeted Therapy and Emerging Applications. | Int J Mol Sci | 2025 | 40243903 | PubTator, text mining | PubMed |
| Germline variants in patients from the Iranian hereditary colorectal cancer registry. | Cancer Cell Int | 2025 | 40223084 | PubTator, text mining | PubMed |
| Werner helicase as a therapeutic target in mismatch repair deficient colorectal cancer. | DNA Repair (Amst) | 2025 | 40203476 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7486/papers?page=6